a developer of immunotherapies for cancer treatment
Industry Biotechnology
A.I.dvisor indicates that over the last year, GRTS has been loosely correlated with VERV. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if GRTS jumps, then VERV could also see price increases.
Ticker / NAME | Correlation To GRTS | 1D Price Change % | ||
---|---|---|---|---|
GRTS | 100% | -4.24% | ||
VERV - GRTS | 44% Loosely correlated | -9.25% | ||
NTLA - GRTS | 33% Loosely correlated | -3.65% | ||
RXRX - GRTS | 33% Loosely correlated | -16.62% | ||
PRTA - GRTS | 32% Poorly correlated | -4.63% | ||
DNA - GRTS | 31% Poorly correlated | -8.82% | ||
More |
Ticker / NAME | Correlation To GRTS | 1D Price Change % |
---|---|---|
GRTS | 100% | -4.24% |
cancer theme (87 stocks) | 33% Poorly correlated | +0.89% |
treatment theme (61 stocks) | 33% Poorly correlated | +0.91% |
pharmaceuticals theme (167 stocks) | 26% Poorly correlated | +0.82% |
immunotherapy theme (13 stocks) | 21% Poorly correlated | -0.95% |